Johnson&Johnson
Stock
Stock
Ticker: JNJ
JNJ
Price
Price
CHART BY
Frequently asked questions
What is Johnson&Johnson's market capitalization?
The market capitalization of Johnson&Johnson is $610.95B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Johnson&Johnson's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Johnson&Johnson is 38.50. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Johnson&Johnson?
Johnson&Johnson's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.592. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Johnson&Johnson's stock?
Currently, 26 analysts cover Johnson&Johnson's stock, with a consensus target price of $283.24. Analyst ratings provide insights into the stock's expected performance.
What is Johnson&Johnson's revenue over the trailing twelve months?
Over the trailing twelve months, Johnson&Johnson reported a revenue of $99.35B.
Is Johnson&Johnson paying dividends?
Yes, Johnson&Johnson is paying dividends. The next payment is scheduled for 08.12.2026, with an expected amount of .
What is the EBITDA for Johnson&Johnson?
Johnson&Johnson's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $33.77B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Johnson&Johnson?
Johnson&Johnson has a free cash flow of $20.59B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Johnson&Johnson have, and what sector and industry does it belong to?
Johnson&Johnson employs approximately 140,800 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Johnson&Johnson's shares?
The free float of Johnson&Johnson is 2.40B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $610.95B
- EPS (TTM)
- $6.592
- Free Float
- 2.40B
- P/E ratio (TTM)
- 38.50
- Revenue (TTM)
- $99.35B
- EBITDA (TTM)
- $33.77B
- Free Cashflow (TTM)
- $20.59B
Pricing
- 1D span
- $266.02$267.06
- 52W span
- $184.67$281.00
Analyst Ratings
The price target is $283.24 and the stock is covered by 26 analysts.
Buy
18
Hold
6
Sell
2
Information
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
- Employees
- 140,800
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- JNJ
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet